Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
Sex Differences in Risk of Severe Adverse Events in Patients Receiving Immunotherapy, Targeted Therapy, or Chemotherapy in Cancer Clinical TrialsUnger, Joseph M ; Vaidya, Riha ; Albain, Kathy S ; LeBlanc, Michael ; Minasian, Lori M ; Gotay, Carolyn C ; Henry, N Lynn ; Fisch, Michael J ; Lee, Shing M ; Blanke, Charles D ; Hershman, Dawn LJournal of clinical oncology, 2022-05, Vol.40 (13), p.1474-1486 [Periódico revisado por pares]United States: Wolters Kluwer HealthTexto completo disponível |
2 |
Material Type: Artigo
|
![]() |
SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder CarcinomaBen-Josef, Edgar ; Guthrie, Katherine A ; El-Khoueiry, Anthony B ; Corless, Christopher L ; Zalupski, Mark M ; Lowy, Andrew M ; Thomas, Jr, Charles R ; Alberts, Steven R ; Dawson, Laura A ; Micetich, Kenneth C ; Thomas, Melanie B ; Siegel, Abby B ; Blanke, Charles DJournal of clinical oncology, 2015-08, Vol.33 (24), p.2617-2622 [Periódico revisado por pares]United States: American Society of Clinical OncologyTexto completo disponível |
3 |
Material Type: Artigo
|
![]() |
In response: Diabetes is a risk factor for the progression and prognosis of COVID‐19Blanke, Charles D.Diabetes/metabolism research and reviews, 2020-10, Vol.36 (7), p.e3331-n/a [Periódico revisado por pares]Chichester, UK: John Wiley & Sons, IncTexto completo disponível |
4 |
Material Type: Artigo
|
![]() |
Clinicopathological and Molecular Characteristics of Early-Onset Stage III Colon Adenocarcinoma: An Analysis of the ACCENT DatabaseJin, Zhaohui ; Dixon, Jesse G ; Fiskum, Jack M ; Parekh, Hiral D ; Sinicrope, Frank A ; Yothers, Greg ; Allegra, Carmen J ; Wolmark, Norman ; Haller, Daniel ; Schmoll, Hans-Joachim ; de Gramont, Aimery ; Kerr, Rachel ; Taieb, Julien ; Van Cutsem, Eric ; Tweleves, Christopher ; O'Connell, Michael ; Saltz, Leonard B ; Sadahiro, Sotaro ; Blanke, Charles D ; Tomita, Naohiro ; Seitz, Jean-Francois ; Erlichman, Charles ; Yoshino, Takayuki ; Yamanaka, Takeharu ; Marsoni, Silvia ; Andre, Thierry ; Mahipal, Amit ; Goldberg, Richard M ; George, Thomas J ; Shi, QianJNCI : Journal of the National Cancer Institute, 2021-11, Vol.113 (12), p.1693-1704 [Periódico revisado por pares]United States: Oxford University PressTexto completo disponível |
5 |
Material Type: Artigo
|
![]() |
Survival in Young-Onset Metastatic Colorectal Cancer: Findings From Cancer and Leukemia Group B (Alliance)/SWOG 80405Lipsyc-Sharf, Marla ; Zhang, Sui ; Ou, Fang-Shu ; Ma, Chao ; McCleary, Nadine Jackson ; Niedzwiecki, Donna ; Chang, I-Wen ; Lenz, Heinz-Josef ; Blanke, Charles D ; Piawah, Sorbarikor ; Van Loon, Katherine ; Bainter, Tiffany M ; Venook, Alan P ; Mayer, Robert J ; Fuchs, Charles S ; Innocenti, Federico ; Nixon, Andrew B ; Goldberg, Richard ; O’Reilly, Eileen M ; Meyerhardt, Jeffrey A ; Ng, KimmieJNCI : Journal of the National Cancer Institute, 2022-03, Vol.114 (3), p.427-435 [Periódico revisado por pares]United States: Oxford University PressTexto completo disponível |
6 |
Material Type: Artigo
|
![]() |
Symposium Introduction: A Decade of the Tobacco Control Act: Progress, Setbacks, and the Future of Tobacco ControlBlanke, D. DouglasThe Journal of legal medicine (Chicago. 1979), 2020-07, Vol.40 (3-4), p.285-291 [Periódico revisado por pares]United States: Taylor & FrancisTexto completo disponível |
7 |
Material Type: Artigo
|
![]() |
S0941: a phase 2 SWOG study of sorafenib and erlotinib in patients with advanced gallbladder carcinoma or cholangiocarcinomaEL-KHOUEIRY, A. B ; RANKIN, C ; SIEGEL, A. B ; IQBAL, S ; GONG, I.-Y ; MICETICH, K. C ; KAYALEH, O. R ; LENZ, H.-J ; BLANKE, C. DBritish journal of cancer, 2014-02, Vol.110 (4), p.882-887 [Periódico revisado por pares]Basingstoke: Nature Publishing GroupTexto completo disponível |
8 |
Material Type: Artigo
|
![]() |
Population, Clinical, and Scientific Impact of National Cancer Institute's National Clinical Trials Network Treatment StudiesUnger, Joseph M ; LeBlanc, Michael ; George, Suzanne ; Wolmark, Norman ; Curran, Jr, Walter J ; O'Dwyer, Peter J ; Schnall, Mitchell D ; Mannel, Robert S ; Mandrekar, Sumithra J ; Gray, Robert J ; Zhao, Fengmin ; Bah, Mariama ; Vaidya, Riha ; Blanke, Charles DJournal of clinical oncology, 2023-04, Vol.41 (11), p.2020-2028 [Periódico revisado por pares]United States: Wolters Kluwer HealthTexto completo disponível |
9 |
Material Type: Artigo
|
![]() |
Assessment of HER2 gene amplification in adenocarcinomas of the stomach or gastroesophageal junction in the INT-0116/SWOG9008 clinical trialGordon, M.A. ; Gundacker, H.M. ; Benedetti, J. ; Macdonald, J.S. ; Baranda, J.C. ; Levin, W.J. ; Blanke, C.D. ; Elatre, W. ; Weng, P. ; Zhou, J.Y. ; Lenz, H.J. ; Press, M.F.Annals of oncology, 2013-07, Vol.24 (7), p.1754-1761 [Periódico revisado por pares]Oxford: Elsevier LtdTexto completo disponível |
10 |
Material Type: Artigo
|
![]() |
A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART SWOG 1609) in Patients with Nonpancreatic Neuroendocrine TumorsPatel, Sandip P ; Othus, Megan ; Chae, Young Kwang ; Giles, Francis J ; Hansel, Donna E ; Singh, Preet Paul ; Fontaine, Annette ; Shah, Manisha H ; Kasi, Anup ; Baghdadi, Tareq Al ; Matrana, Marc ; Gatalica, Zoran ; Korn, W Michael ; Hayward, Jourdain ; McLeod, Christine ; Chen, Helen X ; Sharon, Elad ; Mayerson, Edward ; Ryan, Christopher W ; Plets, Melissa ; Blanke, Charles D ; Kurzrock, RazelleClinical cancer research, 2020-05, Vol.26 (10), p.2290-2296 [Periódico revisado por pares]United StatesTexto completo disponível |